Shuko Oe

Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers

Kiyoshi Hasegawa, Y. Torii, Risa Ishii et al. · Archives of Gynecology and Obstetrics · 2011 · 20 citations

Medicine, Oncology, Pharmacology +6

The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO Stage I to Stage II Uterine Cervical Adenocarcinoma

Kiyoshi Hasegawa, Rina Kato, Y. Torii et al. · International Journal of Gynecological Cancer · 2011 · 19 citations

Medicine, Oncology, Pathology +17

A case of primary uterine cervical neuroendocrine tumor with meningeal carcinomatosis confirmed by diagnostic imaging and autopsy

Shinichi Komiyama, Eiji Nishio, Y. Torii et al. · International Journal of Clinical Oncology · 2010 · 14 citations

Medicine, Oncology, Pathology +11

Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay.

Ryuji Kato, Kiyoshi Hasegawa, Yumiko Achiwa et al. · PubMed · 2011 · 14 citations

Medicine, Oncology, Pharmacology +12

Expression of Podoplanin in Epithelial Ovarian Carcinomas and its Potential as a Marker for Clear Cell Adenocarcinoma

Shuko Oe, Kiyoshi Hasegawa, Sayaka Nagase et al. · International Journal of Gynecological Pathology · 2010 · 13 citations

Medicine, Oncology, Pathology +17